Reduced tonic inhibition after stroke promotes motor performance and epileptic seizures

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Jaenisch, Nadine ^a   Liebmann, Lutz ^a   Guenther, Madlen ^a   Hubner, Christian A ^a   Frahm, Christiane ^a   Witte, Otto W ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR; COTRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POTASSIUM-CHLORIDE SYMPORTERS; PROTEOME;

ANIMAL; CEREBROVASCULAR ACCIDENT; COMPLICATION; DISEASE MODEL; GENE EXPRESSION PROFILING; METABOLISM; MOTONEURON; MOTOR ACTIVITY; MOUSE; PATHOLOGY; PHYSIOLOGY; REGENERATION; SEIZURE;

ANIMALS; DISEASE MODELS, ANIMAL; GABAERGIC NEURONS; GENE EXPRESSION PROFILING; GLUTAMIC ACID; MICE; MOTOR ACTIVITY; MOTOR NEURONS; PROTEOME; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; REGENERATION; SEIZURES; STROKE; SYMPORTERS;

EID: 84971367766     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26173     Document Type: Article

References (70)

1. Donnan, G. A., Fisher, M., Macleod, M., Davis, S. M. Stroke. Lancet 371, 1612-1623 (2008).
2. Witte, O. W., Freund, H. J. Neuronal dysfunction, epilepsy, postlesional brain plasticity. Adv Neurol 81, 25-36 (1999).
3. Langhorne, P., Coupar, F., Pollock, A. Motor recovery after stroke: a systematic review. Lancet Neurol 8, 741-754 (2009).
4. Nudo, R. J. Neural bases of recovery after brain injury. J Commun Disord 44, 515-520 (2011).
5. Witte, O. W. Lesion-induced plasticity as a potential mechanism for recovery and rehabilitative training. Curr Opin Neurol 11, 655-662 (1998).
6. Witte, O. W., Bidmon, H. J., Schiene, K., Redecker, C., Hagemann, G. Functional differentiation of multiple perilesional zones after focal cerebral ischemia. J Cereb Blood Flow Metab 20, 1149-1165 (2000).
7. Craig, L. E., Bernhardt, J., Langhorne, P., Wu, O. Early mobilization after stroke: an example of an individual patient data metaanalysis of a complex intervention. Stroke 41, 2632-2636 (2010).
8. Biernaskie, J., Chernenko, G., Corbett, D. Efficacy of rehabilitative experience declines with time after focal ischemic brain injury. J Neurosci 24, 1245-1254 (2004).
9. Momosaki, R. et al. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study. Cerebrovasc Dis 42, 41-48 (2016).
10. Awad, A. J., Kellner, C. P., Mascitelli, J. R., Bederson, J. B., Mocco, J. No Early Mobilization After Stroke: Lessons Learned from the AVERT Trial. in World Neurosurg 474 (2016).
11. Bernhardt, J. et al. Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT). Neurology, doi: 10.1212/WNL.0000000000002459 (2016).
12. Stagg, C. J., Bachtiar, V., Johansen-Berg, H. The role of GABA in human motor learning. Curr Biol 21, 480-484 (2011).
13. Bachtiar, V., Stagg, C. J. The role of inhibition in human motor cortical plasticity. Neuroscience 278C, 93-104 (2014).
14. Clarkson, A. N., Huang, B. S., Macisaac, S. E., Mody, I., Carmichael, S. T. Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke. Nature 468, 305-309 (2010).
15. Epsztein, J., Ben-Ari, Y., Represa, A., Crepel, V. Late-onset epileptogenesis and seizure genesis: lessons from models of cerebral ischemia. Neuroscientist 14, 78-90 (2008).
16. Sieber, M. W. et al. Age-specific transcriptional response to stroke. Neurobiol Aging 35, 1744-1754 (2014).
17. Thom, T. et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, e85-151 (2006).
18. Chiang, T., Messing, R. O., Chou, W. H. Mouse model of middle cerebral artery occlusion. J Vis Exp (2011).
19. Helmstaedter, M., Staiger, J. F., Sakmann, B., Feldmeyer, D. Efficient recruitment of layer 2/3 interneurons by layer 4 input in single columns of rat somatosensory cortex. J Neurosci 28, 8273-8284 (2008).
20. Olsen, R. W., Sieghart, W. GABA A receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology 56, 141-148 (2009).
21. Mohler, H. GABA(A) receptor diversity and pharmacology. Cell Tissue Res 326, 505-516 (2006).
22. Hiu, T. et al. Enhanced phasic GABA inhibition during the repair phase of stroke: a novel therapeutic target. Brain 139, 468-480 (2016).
23. Redecker, C., Wang, W., Fritschy, J. M., Witte, O. W. Widespread and long-lasting alterations in GABA(A)-receptor subtypes after focal cortical infarcts in rats: mediation by NMDA-dependent processes. J Cereb Blood Flow Metab 22, 1463-1475 (2002).
24. Schaar, K. L., Brenneman, M. M., Savitz, S. I. Functional assessments in the rodent stroke model. Exp Transl Stroke Med 2, 13 (2010).
25. Rogers, D. C., Campbell, C. A., Stretton, J. L., Mackay, K. B. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28, 2060-2065+ADs-discussion 2066 (1997).
26. Schabitz, W. R. et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke 35, 992-997 (2004).
27. Drasbek, K. R., Jensen, K. THIP, a hypnotic and antinociceptive drug, enhances an extrasynaptic GABAA receptor-mediated conductance in mouse neocortex. Cereb Cortex 16, 1134-1141 (2006).
28. You, H., Dunn, S. M. Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity. J Neurochem 103, 1092-1101 (2007).
29. Bonin, R. P. et al. Pharmacological enhancement of delta-subunit-containing GABA(A) receptors that generate a tonic inhibitory conductance in spinal neurons attenuates acute nociception in mice. Pain 152, 1317-1326 (2011).
30. Herd, M. B. et al. Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo-4,5-c+AF0-pyridine-3-ol: a selective role for delta-GABA(A) receptors. Eur J Neurosci 29, 1177-1187 (2009).
31. Cremers, T., Ebert, B. Plasma and CNS concentrations of Gaboxadol in rats following subcutaneous administration. Eur J Pharmacol 562, 47-52 (2007).
32. Mortensen, M., Ebert, B., Wafford, K., Smart, T. G. Distinct activities of GABA agonists at synaptic-and extrasynaptic-type GABAA receptors. J Physiol 588, 1251-1268 (2010).
33. Loscher, W. Preclinical assessment of proconvulsant drug activity and its relevance for predicting adverse events in humans. Eur J Pharmacol 610, 1-11 (2009).
34. Hansen, S. L., Sperling, B. B., Sanchez, C. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuropsychopharmacol Biol Psychiatry 28, 105-113 (2004).
35. Rothman, S. M., Olney, J. W. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann Neurol 19, 105-111 (1986).
36. Lee, H. H., Deeb, T. Z., Walker, J. A., Davies, P. A., Moss, S. J. NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currents. Nat Neurosci 14, 736-743 (2011).
37. Puskarjov, M., Ahmad, F., Kaila, K., Blaesse, P. Activity-dependent cleavage of the K-Cl cotransporter KCC2 mediated by calciumactivated protease calpain. J Neurosci 32, 11356-11364 (2012).
38. Jaenisch, N., Witte, O. W., Frahm, C. Downregulation of potassium chloride cotransporter KCC2 after transient focal cerebral ischemia. Stroke 41, e151-159 (2010).
39. Succol, F., Fiumelli, H., Benfenati, F., Cancedda, L., Barberis, A. Intracellular chloride concentration influences the GABAA receptor subunit composition. Nat Commun 3, 738 (2012).
40. Papp, E., Rivera, C., Kaila, K., Freund, T. F. Relationship between neuronal vulnerability and potassium-chloride cotransporter 2 immunoreactivity in hippocampus following transient forebrain ischemia. Neuroscience 154, 677-689 (2008).
41. Fuchs, A. et al. Downregulation of the potassium chloride cotransporter KCC2 in vulnerable motoneurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 69, 1057-1070 (2010).
42. Lee, H. H., Jurd, R., Moss, S. J. Tyrosine phosphorylation regulates the membrane trafficking of the potassium chloride cotransporter KCC2. Mol Cell Neurosci 45, 173-179 (2010).
43. Silayeva, L. et al. KCC2 activity is critical in limiting the onset and severity of status epilepticus. Proc Natl Acad Sci USA 112, 3523-3528 (2015).
44. Rivera, C. et al. BDNF-induced TrkB activation down-regulates the Kcotransporter KCC2 and impairs neuronal Clextrusion. J Cell Biol 159, 747-752 (2002).
45. Tornberg, J. et al. KCC2-deficient mice show reduced sensitivity to diazepam, but normal alcohol-induced motor impairment, gaboxadol-induced sedation, neurosteroid-induced hypnosis. Neuropsychopharmacology 32, 911-918 (2007).
46. Schmidt, S. Bruehl, C., Frahm, C., Redecker, C., Witte, O. W. Age dependence of excitatory-inhibitory balance following stroke. Neurobiol Aging 33, 1356-1363 (2012).
47. Scholz, J., Niibori, Y., Frankland, P. W., Lerch, J. P. Rotarod training in mice is associated with changes in brain structure observable with multimodal MRI. Neuroimage 107, 182-189 (2015).
48. Hunter, A. J. et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology 39, 806-816 (2000).
49. Li, H., et al. Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol Dis 54, 216-224 (2013).
50. Blicher, J. U. et al. GABA levels are decreased after stroke and GABA changes during rehabilitation correlate with motor improvement. Neurorehabil Neural Repair 29, 278-286 (2015).
51. Martinez-Cue, C., et al. Reducing GABAA alpha5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome. J Neurosci 33, 3953-3966 (2013).
52. Hernandez, T. D., Schallert, T. Long-term impairment of behavioral recovery from cortical damage can be produced by short-term GABA-agonist infusion into adjacent cortex. Restor Neurol Neurosci 1, 323-330 (1990).
53. Johnston, G. A. Muscimol as an ionotropic GABA receptor agonist. Neurochem Res 39, 1942-1947 (2014).
54. Egawa, K. et al. Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in a mouse model of Angelman syndrome. Sci Transl Med 4, 163-157 (2012).
55. Olmos-Serrano, J. L., Corbin, J. G., Burns, M. P. The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome. Dev Neurosci 33, 395-403 (2011).
56. Draper, A. et al. Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome. Curr Biol 24, 2343-2347 (2014).
57. Spigelman, I. et al. Behavior and physiology of mice lacking the GABAA-receptor delta subunit. Epilepsia 43 Suppl 5, 3-8 (2002).
58. Dibbens, L. M. et al. GABRD encoding a protein for extra-or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13, 1315-1319 (2004).
59. Hirose, S. Mutant GABA(A) receptor subunits in genetic (idiopathic) epilepsy. Prog Brain Res 213, 55-85 (2014).
60. Mulley, J. C., Scheffer, I. E., Harkin, L. A., Berkovic, S. F., Dibbens, L. M. Susceptibility genes for complex epilepsy. Hum Mol Genet 14 Spec No. 2, R243-249 (2005).
61. Brickley, S. G., Mody, I. Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease. Neuron 73, 23-34 (2012).
62. Hubner, C. A. The KCl-cotransporter KCC2 linked to epilepsy. EMBO Rep 15, 732-733 (2014).
63. Mihalek, R. M. et al. Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice. Proc Natl Acad Sci USA 96, 12905-12910 (1999).
64. Popp, A., Jaenisch, N., Witte, O. W., Frahm, C. Identification of ischemic regions in a rat model of stroke. Plos One 4, e4764 (2009).
65. Sieber, M. W. et al. Inter-age variability of bona fide unvaried transcripts Normalization of quantitative PCR data in ischemic stroke. Neurobiol Aging 31, 654-664 (2010).
66. Sinning, A. et al. Synaptic glutamate release is modulated by the Na+driveg-Cl-/HCO3-exchanger Slc4a8. J Neurosci 31, 7300-7311 (2011).
67. Holter, N. I., Zylla, M. M., Zuber, N., Bruehl, C., Draguhn, A. Tonic GABAergic control of mouse dentate granule cells during postnatal development. Eur J Neurosci 32, 1300-1309 (2010).
68. Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45 (2001).
69. Lee, H. H. et al. Direct protein kinase C-dependent phosphorylation regulates the cell surface stability and activity of the potassium chloride cotransporter KCC2. J Biol Chem 282, 29777-29784 (2007).
70. Paxinos, G., Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates (Academic Press, San Diego, 2001).